Dotmatics Acquires EasyPanel to Expand Flow Cytometry Capabilities With Advanced Panel Design
Dotmatics has acquired EasyPanel, a company specializing in automated flow cytometry panel design software, to enhance its flow cytometry solutions by integrating advanced panel design capabilities that optimize experimental workflows from initial design through data analysis, complementing its existing tools like OMIQ and FCS Express.
The Addition Expands Dotmatics Flow Cytometry Solutions Covering the End-to-End Workflow From Experimental Design to Downstream Data Analysis
BOSTON, MA - July 30, 2024 – Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, announced the successful acquisition of EasyPanel, a high-growth company specializing in flow cytometry panel design software. The acquisition marks another milestone for Dotmatics, expanding the breadth and depth of its flow cytometry solutions. EasyPanel is the 14th acquisition by Dotmatics in its work to provide scientists with best-in-class scientific software and a comprehensive scientific intelligence platform for multimodal scientific research & development.
EasyPanel offers an innovative flow cytometry product that is highly complementary to Dotmatics’ existing capabilities with OMIQ and FCS Express. Its intelligent and automated flow cytometry panel designer utilizes a proprietary algorithm to suggest optimized panels based on a customer's test environment for improved experimental impact. Users can also manually edit the suggested panels, receive smart recommendations for gating strategies, and automatically manage their antibody inventory.
Flow cytometry panel design refers to the process of selecting and combining specific fluorophores and antibodies to analyze multiple parameters (such as cell surface markers, intracellular proteins, and viability indicators) simultaneously on individual cells within a biological sample.
It is the initial step in the flow cytometry phenotyping process, occurring before panel preparation in the wet lab, data acquisition on a flow cytometer, and subsequent analysis using software like FCS Express and OMIQ.
EasyPanel gives Dotmatics a more comprehensive approach to flow cytometry by adding panel design capabilities which will greatly enhance its current offerings, enabling Dotmatics to provide even more robust solutions to its customers.
“Our flow cytometry customers are working with increasingly sophisticated panels for high dimensional assays, which in turn are generating large amounts of complex data for subsequent analysis,” said Brett Ammundsen, President of Bioinformatics at Dotmatics. “EasyPanel’s panel design permits R&D scientists to generate high quality data at the outset, enabling the full potential of that data to be realized in experimental outcomes when analyzed in software such as OMIQ and FCS Express. Higher quality data also supports increased downstream automation in the analysis of flow cytometry panels. The acquisition of EasyPanel supports our commitment to deliver reliable machine learning and AI tools for advanced automation of flow cytometry analysis, comprising innovations that we’re building into OMIQ, FCS Express, and Dotmatics Luma.”
“This is a big opportunity for EasyPanel to grow and scale our business and help create end-to-end flow solutions together with Dotmatics.” said Omar Abouzid, co-founder and President of EasyPanel. “Our customers and partners can expect the same level of support from EasyPanel as they have received in the past, but now with the benefit of having additional resources and involvement from the Dotmatics flow cytometry team.”
For more information please visit www.easypanel.ai and www.dotmatics.com
About Dotmatics
Dotmatics is a leader in R&D scientific software connecting science, data, and decision-making. Its enterprise R&D platform and scientists’ favorite applications drive efficiency and accelerate innovation. More than 2 million scientists and 10,000 customers trust Dotmatics to help them create a healthier, cleaner, safer world. Dotmatics is a global team of more than 800 people dedicated to supporting its customers in over 180 countries. Dotmatics has made 14 acquisitions since 2017. The company’s principal office is in Boston, with 14 offices and R&D teams located around the world.
Dotmatics is backed by Insight Partners, a leading global venture capital and private equity firm investing in high-growth technology and software scaleup companies. Learn more about Dotmatics, its platform, and applications including GraphPad Prism, Geneious, SnapGene, Protein Metrics, LabArchives, OMIQ, and FCS Express at https://www.dotmatics.com/.
Media Contacts
Cory Edwards
Vice President, Corporate Communications, Dotmatics
(801) 386-1960
cory.edwards@dotmatics.com
Jerome Combes-Knoke
Senior Vice President, Strategy & Corporate Development, Dotmatics
corpdev@dotmatics.com
Related
Beyond Manual Gating: A Practical Guide to Modern Flow Cytometry Data Analysis
The article discusses the growing challenges in flow cytometry data analysis due to massive data volumes and increasing dimensionality from advanced cytometers, highlighting that traditional manual gating methods are becoming unsustainable and emphasizing the need for modern, automated analytical approaches to efficiently process and interpret complex, high-dimensional flow cytometry datasets.
End-to-End Flow Cytometry Workflow Optimization with Luma + OMIQ
Dotmatics addresses the challenges of manual data handling in flow cytometry workflows by integrating technologies like Luma and OMIQ to automate dataflows, minimize errors, and provide a seamless, end-to-end solution that unites instrument data, advanced analysis tools, and FAIR-compliant data management for optimized panel design, experiment planning, data acquisition, analysis, visualization, and contextualization.
Modernizing Flow Cytometry Analysis to Accelerate Oncology R&D Innovation
The Dotmatics Luma Flow Cytometry Workflow modernized a major US pharma's oncology R&D by automating data uploads, intelligent tagging, centralized storage, and advanced cloud-based analysis, resulting in rapid deployment, significant time savings per scientist, improved data accessibility, seamless sharing, and enhanced analytical insights.
Reimagined Flow Cytometry Software
The Dotmatics Flow Cytometry solution integrates three leading platforms—OMIQ, Cytapex, and FCS Express—to deliver a powerful, flexible, and clinically validated software suite that combines classic and high-dimensional flow cytometry analysis with machine learning, automation, robust data management, and multi-user collaboration, designed to accelerate scientific innovation and meet enterprise and clinical needs.
Luma Flow Cytometry
Luma Flow Cytometry is a cloud-native, AI-ready platform that streamlines and modernizes flow cytometry data analysis and reporting by integrating advanced machine learning, real-time collaboration, automated data uploads, and compliance-ready traceability to accelerate high-dimensional immunophenotyping and regulated workflows across organizations.
Insightful Science Acquires Omiq
Insightful Science has acquired Omiq Inc, a company offering the cloud-based SaaS platform OMIQ that provides advanced machine learning and analytical tools for high-dimensional flow cytometry and multi-omics data, thereby enhancing Insightful Science’s flow cytometry software portfolio and enabling integrated, efficient workflows for biopharma research organizations.